MTND4P2

Across TCGA pan-cancer cohorts, MTND4P2 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MTND4P2 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MTND4P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND4P2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUSC show a favorable association.

LUAD, HNSC, and LUSC are the cancer types where MTND4P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.233	0.766	<.001	54	view →
HNSC	DFS	Tertile	II,III,IV	0.574	0.290	.008	33	view →
LUSC	DFS	Tertile	II,III,IV	0.988	0.698	.013	27	view →
LAML	DFS	Tertile	All	0.707	0.468	.004	22	view →
KIRC	DFS	Quartile	IV	0.226	0.504	.023	18	view →
SARC	OS	Tertile	All	0.683	0.870	.018	6	view →
PCPG	OS	Tertile	All	0.884	0.980	.013	6	view →
ESCA	DFS	Quartile	All	0.351	0.522	.038	2	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MTND4P2–LUAD (OS)

Open the LUAD breakdown →